Hanmi Pharmaceutical's first domestically developed GLP-1 obesity drug has won regulatory approval in Korea, setting up ...

Hanmi Pharmaceutical’s obesity drug Epe has won regulatory approval and is set to launch by year-end, becoming South Korea’s ...

Industry publication BioPharma APAC evaluated mergers and acquisitions, licensing deals and structured partnerships involving Asia-Pacific companies signed or completed between Jan. 1 and Sept. 23, ...

[by Ji, Yong Jun] Korea’s first domestically developed obesity drug in the glucagon-like peptide-1 (GLP-1) class has arrived: ...

HK inno.N said Tuesday its obesity drug cut body weight by up to 12 percent in teenagers in an early-stage trial. The drug, ...

Actress Son Tae-young shared her thoughts on the so-called "bone-thin" trend of favoring an excessively thin body. She said that aging healthily is now more important than losing weight and that she h ...

[서울=뉴시스]이소헌 기자 = 한미약품이 개발한 국내 첫 GLP-1 계열 비만치료제 신약 '에페'(EPPE)가 식품의약품안전처 허가를 받아 국내 45번째 신약이 된 가운데, 해당 치료제에 대한 관심이 쏠리고 있다.7일 ...

“이거, 인슐린을 맞지 않는 사람이 착용해도 의미가 있나요?”팔 뒤쪽에 작은 센서를 붙이고 휴대폰으로 혈당의 움직임을 확인한다. 지속 혈당 측정, 이른바 CGM입니다. 당뇨병으로 인슐린을 사용하는 분들의 도구라는 인상이 ...

A study has found that children of mothers who had diabetes during pregnancy face a higher risk of developing diabetes as they grow. The National Institute of Health of the Korea Disease Control ...

Following obesity treatments, hair-loss treatments are emerging as a new investment opportunity. Heung-Tae Kim, a manager at MBN Gold, introduces changes in the hair-loss treatment market and key inve ...

9월 전국 민간아파트 평균 분양가 전월보다 0.96% 상승 광주 8.52% 올라 상승폭 최대…분당선 ㎡당 3365만원 기록 기본형건축비·공사비 상승 지속…"당분간 분양가 하락 쉽지 않아" [아시아타임즈=이현주 기자] 전국 ...

The Ministry of Food and Drug Safety on Thursday approved Hanmi Pharmaceutical's Eppe, Korea's first domestically developed ...